May 23, 2022
Video
Patients who have IPAA are more than twice as likely to suffer from male sexual dysfunction.
Dr. Blount discusses the DDW 2022 poster of distinction on the investigational live biotherapeutic.
May 22, 2022
Amid significant psychotherapy innovation and consideration to broader aspects of mental illness definition, Jonathan Alpert, MD, PhD, emphasizes the need for improved clinical trial standards.
New phase 3 data presented at APA 2022 support the agent as an adjunctive in older patients without benefit from monotherapy antidepressant medication.
Montefiore psychiatry chair Jonathan Alpert, MD, PhD, discusses suggested updates to the DSM-5—with consideration to social determinants and patient-reported functioning.
Linda Chokroverty, MD, discusses the significance of timing, communication and care coordination when children are affected by disasters or trauma.
APA president-elect Rebecca W. Brendel, MD, JD, discusses the need to prepare for a "twin mental health pandemic" while continuing to appropriately facilitate innovations in psychiatric care.
Anita Clayton, MD, reviews the available phase 2 and 3 clinical data for the novel, once-daily oral investigative drug.
May 21, 2022
Linda Chokroverty, MD, discusses the role psychiatrists play in managing the mental health effects of disasters, and how children specifically may be impacted.
A pair of psychiatrists discuss how climate change and other social determinants of health are affecting the mental wellbeing of indigenous people.
SER-109 Results in Increase in Microbe-Producing Metabolites
Taha Qazi, MD: Male Sexual Dysfunction Following Ulcerative Colitis Surgery
TNF-Antagonist Therapy Linked to Better Outcomes for Post-Operative Crohn’s Disease